Supplementary Figure 9 from Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming
Year: 2026
Type: supplementary-materials
Abstract: GPR84 antagonism improves anti-tumor therapeutic vaccine efficacy in an in vivo multi-boost immunization regimen.
Authors: Phaethon Philbrook, Matthew J. Dean, Maria Dulfary Sanchez-Pino, Li Qin Zheng, Jovanny Zabaleta, Julio A. Vázquez-Martínez, Darwin Chang, Jessica K. Mandula, Timothy I. Shaw, Dorota Wyczechowska, Jone Garai, Ramesh Thylur Puttalingaiah, Amirsalar Mansouri, Weishan Huang, Satyajit Das, Shiun Chang, José R. Conejo-Garcia, Paulo C. Rodriguez, Augusto C. Ochoa
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W7147545329
Cites:
Cited by:
Related to: